Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs) miniperspective

K Ling, F Men, WC Wang, YQ Zhou… - Journal of Medicinal …, 2017 - ACS Publications
Carbon monoxide (CO) is attracting increasing attention because of its role as a
gasotransmitter with cytoprotective and homeostatic properties. Carbon monoxide releasing …

The therapeutic potential of carbon monoxide

R Motterlini, LE Otterbein - Nature reviews Drug discovery, 2010 - nature.com
Carbon monoxide (CO) is increasingly being accepted as a cytoprotective and homeostatic
molecule with important signalling capabilities in physiological and pathophysiological …

Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation

SW Ryter, AMK Choi - Translational Research, 2016 - Elsevier
The heme oxygenase-1 (HO-1) enzyme system remains an attractive therapeutic target for
the treatment of inflammatory conditions. HO-1, a cellular stress protein, serves a vital …

Carbon monoxide signaling: examining its engagement with various molecular targets in the context of binding affinity, concentration, and biologic response

Z Yuan, LK De La Cruz, X Yang, B Wang - Pharmacological Reviews, 2022 - ASPET
Carbon monoxide (CO) has been firmly established as an endogenous signaling molecule
with a variety of pathophysiological and pharmacological functions, including …

Use of carbon monoxide as a therapeutic agent: promises and challenges

R Foresti, MG Bani-Hani, R Motterlini - Intensive Care Medicine, 2008 - Springer
As a by-product of heme catabolism by the heme oxygenase system, carbon monoxide (CO)
has been neglected for many years, and only recently has its role as an essential signaling …

Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs)

HI Choi, A Zeb, MS Kim, I Rana, N Khan… - Journal of Controlled …, 2022 - Elsevier
Carbon monoxide (CO) has been regarded as a “silent killer” for its toxicity toward biological
systems. However, a low concentration of endogenously produced CO has shown a number …

Carbon monoxide in lung cell physiology and disease

SW Ryter, KC Ma, AMK Choi - American Journal of …, 2018 - journals.physiology.org
Carbon monoxide (CO) is an endogenously produced gas that has gained recognition as a
biological signal transduction effector with properties similar, but not identical, to that of nitric …

Heme oxygenase-1: a metabolic nike

B Wegiel, Z Nemeth, M Correa-Costa… - Antioxidants & redox …, 2014 - liebertpub.com
Significance: Heme degradation, which was described more than 30 years ago, is still very
actively explored with many novel discoveries on its role in various disease models every …

[HTML][HTML] A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS

LE Fredenburgh, MA Perrella, D Barragan-Bradford… - JCI insight, 2018 - ncbi.nlm.nih.gov
BACKGROUND. Acute respiratory distress syndrome (ARDS) is a prevalent disease with
significant mortality for which no effective pharmacologic therapy exists. Low-dose inhaled …

Heme oxygenase and carbon monoxide initiate homeostatic signaling

M Bilban, A Haschemi, B Wegiel, BY Chin… - Journal of Molecular …, 2008 - Springer
Carbon monoxide (CO), a gaseous second messenger, arises in biological systems during
the oxidative catabolism of heme by the heme oxygenase (HO) enzymes. Many biological …